RE:. Cost for Leronlimab in CV indication... A
Post# of 148172
(Total Views: 1267)
Posted On: 03/30/2020 10:46:58 PM
RE:. Cost for Leronlimab in CV indication...
A member of my investment group pointed this out to me today. Let's remember that the costs that we have been quoted are annual costs, but most CV patients will need the drug for maximum of 6 weeks (I believe according to the trial protocol).
So a $60,000 annual cost becomes a $7000 treatment per CV patient.
This also helps with the supply issues we've discussed.
Ultimately, CV may not be a huge profit center for CYDY, but it may serve to put the company on the map finally and advance the HIV and cancer indications at warp speed.
Wow, what a roller coaster this is going to be...
A member of my investment group pointed this out to me today. Let's remember that the costs that we have been quoted are annual costs, but most CV patients will need the drug for maximum of 6 weeks (I believe according to the trial protocol).
So a $60,000 annual cost becomes a $7000 treatment per CV patient.
This also helps with the supply issues we've discussed.
Ultimately, CV may not be a huge profit center for CYDY, but it may serve to put the company on the map finally and advance the HIV and cancer indications at warp speed.
Wow, what a roller coaster this is going to be...
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼